trending Market Intelligence /marketintelligence/en/news-insights/trending/d3foth1mukoobn-bd6mzjg2 content esgSubNav
In This List

Acerus Pharmaceuticals names CEO

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism


Acerus Pharmaceuticals names CEO

Acerus Pharmaceuticals Corp. appointed Edward Gudaitis as president and CEO, effective May 1.

Luc Mainville will continue to act as interim CEO of the company and work with Gudaitis to ensure a smooth transition.

Following the transition, Mainville will resume his position as a board member.

Gudaitis most recently served as vice president and general manager of Allergan PLC's Allergan Canada.